Hunan Dadi Tongnian Biotechnology Co., Ltd. was established in July 2016. It is a wholly-owned subsidiary of Qingdao Dadi Tongnian Biotechnology Co., Ltd., fully funded by Huayao Capital, which was jointly established by the National Strategic Emerging Industry Venture Capital Plan Fund, the Qingdao Municipal Government Venture Capital Guidance Fund, Shandong Binhua Group, Shanghai Fosun Group, and others. It is managed by a technical operations team composed of master's degree holders, doctoral degree holders, and professors in fields such as medical genetics, immunology, oncology, and stem cell engineering.
The company is committed to building itself into a precision medicine product and service provider with high-tech biomedical technology research and development capabilities, offering services such as disease susceptibility gene testing, early tumor screening, personalized medication guidance for diseases, and genetic disease diagnosis to the general physical examination market, high-end populations, and hospital patients. At the same time, the company has strong research and development capabilities. Its research and development products cover personalized disease gene chips, immune repertoire sequencing, gut microbiome sequencing, liquid biopsy kits, gene big data analysis systems, stem cell and immune cell therapy, etc., providing precision solutions for the prevention, diagnosis, and treatment of human diseases.
Company official website:
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
